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bstract
The inhibitory effects of a formulated product from citrus peel extract, Gold Lotion (GL), on 12-O-tetradecanoylphorbol 13-acetate (TPA)-induced
xpression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in mouse skin was reported in this study. It is found that in the
PA-induced skin inflammation model, the topical application of GL effectively inhibited the transcriptional activation of iNOS and its mRNA and
rotein in mouse skin. It is also discovered that GL significantly inhibited TPA-induced mouse skin inflammation by decreasing inflammatory gene
arameters. Furthermore, GL dramatically inhibited 7,12-dimethylbenez[a]anthracene (DMBA)/TPA-induced skin tumor formation and reduced
umor incidence, tumor weight and tumor multiplicity of papillomas at 20 weeks. In essence, these in  vivo  data have revealed that GL is an
ffective anti-tumor agent that functions by down-regulating the protein levels of COX-2, ornithine decarboxylase (ODC), and vascular endothelial
rowth factor (VEGF) in mouse skin, suggesting that GL is a novel functional natural product capable of preventing inflammation-associated
umorigenesis.
 2012 Production and hosting by Elsevier B.V. on behalf of Beijing Academy of Food Sciences.
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.  Introduction
Citrus peel is rich in flavonoids including methylated deriva-
ives such as polymethoxyflavones (PMFs). Flavonoids are
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MP-9, matrix metalloproteinase-9; PCR, polymerase chain reaction; GL, Gold
otion.
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Sypically found throughout the whole fruit whereas PMFs are
ound exclusively in the peels of Citrus  genus, particularly
n the peels of sweet oranges (Citrus  sinensis) and mandarin
ranges (Citrus  reticulate). PMFs have been shown to exhibit a
road spectrum of biological activity including cancer preven-
ion, inhibition of inflammation, and anti-tumor properties [1–4].
t has been suggested that the consumption of citrus fruits may
revent the development of certain human cancers. It is also
ommonly recognized that cancer induction can be prevented
y certain food phytochemicals, and flavonoids in Citrus  fruits
nd juices have been recognized as prominent cancer preventing
gents [5,6].
Gold lotion (GL), made from the peels of 6 citrus  fruits
vailable in Japan, namely, navel  oranges, citrus  hassaku, citrus
imon, citrus  natsudaidai, citrus  miyauchi  and satsuma, was ini-
ially developed as a cosmetic product to protect skin from UV
rradiation. Consumers later reported anecdotal evidence that
L possessed anti-cancer property based on topical application
f GL to treat melanoma, and oral ingestion for prostate, lung
nd liver cancers. After two years (1984–1986) of safety evalua-
ion, GL was found to be non-toxic by the Huntingdon Research
enter in UK (Reports from Miyauchi Citrus Research Center).
ubsequent chemical analysis of GL has revealed the abundant
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xistence of flavonoids and PMFs, which stimulated us to fur-
her investigate its anti-inflammation and anti-cancer activity
ystematically in animal models.
Previous research has shown that inflammation is causally
inked to carcinogenesis and acts as a driving force in premalig-
ant and malignant transformation of cells [7]. In the past two
ecades, mouse skin models have been developed to elucidate
he mechanism of inflammation as it relates to tumor promotion
nd progression [8]. In skin, the epidermis is the main target
or various initiators and promoters. In the mouse skin model
f acute inflammation, TPA has been used as a potent tumor
romoter. In addition to tumor promotion, TPA also causes
esponses in mouse skin such as arachidonic acid cascade and
pidermal ornithine decarboxylase (ODC) induction [9,10].
oreover, TPA also induces epidermal cell proliferation,
ecruits inflammatory cells, increases production of reactive
xygen species (ROS) leading to oxidative DNA damage, and
educes DNA repairing capability. More importantly, topical
pplication of TPA to mice leads to edema and papilloma forma-
ion by enhancing the expression of inflammatory enzymes such
s inducible nitric oxide synthase (iNOS) and cyclooxygenase-2
COX-2) [11]. Studies show that COX-2 and iNOS are impor-
ant enzymes that mediate a majority of known inflammatory
rocesses. Additionally, up-regulation of COX-2 and/or iNOS
as been associated with the pathophysiology of certain types
f human cancers as well as inflammatory disorders [12].
The mouse skin model has been used for decades as a
eliable and conventional model for studying the mechanisms
f carcinogenesis and modulation of sequential steps involved in
he process [13]. Skin tumors can be induced by the sequential
pplication of a sub-threshold dose of a carcinogen (initiation
tage) followed by repetitive treatment with a non-carcinogenic
romoter [14]. Topical application of TPA, the classical tumor
romoter to mouse skin, has been shown to generate a number
f biochemical alterations, changes in cellular functions, and
istological changes leading to skin tumor promotion [15]. The
hanges that have exhibited the highest correlation with skin
umor-promoting activity of TPA include skin edema, epidermal
yperplasia, inflammation, proliferation and oxidative stress
16]. The skin changes have been defined as biomarkers of skin
umor promotion, and could be used to evaluate the potency of
hemo-preventive agents against tumorigenesis [17,18].
In the present study, we have investigated the effectiveness
f GL on TPA-induced iNOS, COX-2, and ODC expression
n mouse skin; evaluated the anti-inflammatory activity of GL
n mouse skin following TPA application, and explored the
nhibitory effect of GL on mouse skin tumorigenesis using a
wo-stage skin carcinogenesis model by the evaluation of tumor
ncidence, multiplicity, and volume.
. Materials  and  methods
.1.  Animal  treatmentFemale ICR mice at 5–6 weeks’ old were supplied by the
ioLASCO Experimental Animal Center (Taiwan Co., Ltd.,
ioLASCO, Taipei, Taiwan). All animals were housed in a
c
R
p
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ontrolled atmosphere (25 ±  1 ◦C at 50% relative humidity) and
ith a 12-h light/12-h dark cycle. The dorsal skin of each mouse
as shaved with surgical clippers prior to application of each
ested compound. GL and TPA were dissolved in 200 L of
cetone and applied topically to the shaved area of each mouse.
.2. Measurement  of  epidermal  hyperplasia
To measure epidermal thickness, skin samples from different
reatment groups were fixed in 10% formalin and embedded in
araffin for histological examination. Sections (4 m in thick-
ess) of the skin samples were cut and mounted on polylysine-
oated slides. Each section was de-paraffinized in xylene,
ehydrated through a series of graded alcohols and stained with
ematoxylin and eosin. The thickness of the epidermis was mea-
ured using a Nikon light microscope (Japan) equipped with
n ocular micrometer at 400×  magnification and 15 fields per
ection. The number of leukocytes infiltrating the dermis was
etermined by counting the stained cells at 5 different locations.
.3. Western  blot  analysis
The female ICR mice were topically treated on their shaved
acks with GL applied 30 min prior to treatment with 10 nmol
f TPA. The mice were killed by cervical dislocation at sched-
led time. For protein isolation from mouse skin, the mouse
orsal skins derived from different experiments were excised.
ollowing fat removal from the dorsal skin on ice, the skin sam-
les were immediately placed in liquid nitrogen. The epidermal
rotein was homogenized on ice for 15 s with a polytron tis-
ue homogenizer and lysed in 0.5 mL of ice-cold lysis buffer
ollowed by centrifugation at 10,000 ×  g  for 30 min at 4 ◦C.
roteins in the cytosolic fraction (supernatant) were measured
y Bio-Rad protein assay. A total of 50 g protein was boiled
n sodium dodecyl sulfate (SDS) sample loading buffer for
0 min before electrophoresis on 12% SDS–polyacrylamide gel.
fter electrophoresis for 2 h, proteins in SDS–polyacrylamide
el were transferred to PVDF membrane (Gelman Laboratory,
nn Arbor, MI), and the blots were blocked with 5% non-fat
ry milk-PBST buffer [phosphate–buffer saline (PBS) con-
aining 0.1% Tween-20] for 60 min at room temperature. The
embranes were incubated for 2 h at room temperature with
NOS, COX-2, COX-1 and -actin antibodies at a dilution ratio
f 1:1000.
.4.  Reverse  transcription-polymerase  chain  reaction
RT-PCR)
Total RNA was isolated from scraped colon mucosa using
rizol Reagent according to the manufacturer’s instruction
Invitrogen, Carlsbad, CA, USA). Changes in the steady-state
oncentration of mRNA in iNOS, COX-2 and -actin were
ssessed by RT-PCR. A total of 2 g RNA was transcribed into
DNA using SuperScript II Reverse Transcriptase (Invitrogen,
enfrewshire, UK) in a final volume of 20 L. RT reactions were
erformed at 50 ◦C for 50 min and 70 ◦C for 15 min using a Gene
ycler thermal cycler (Bio-Rad). The thermal cycle conditions
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ere initiated at 95 ◦C for 1 min, followed by 30 cycles of ampli-
cation (94 ◦C for 30 s, 58 ◦C for 25 s, and 72 ◦C for 1 min),
nd a final extension at 72 ◦C for 3 min. The complementary
NA was amplified by PCR with the following primers: iNOS,
orward primer 5′-CCCTTCCGAAGTTTCTGGCAGCAGC-3′
2944–2968), reverse primer 5′-GGCTGTCAGAGAGCCTCG-
GGCTTTGG-3′ (3416–3440); COX-2, forward primer 5′-GG-
GAGACTATCAAGATAGTGATC-3′ (1094–1117),
everse primer 5′-ATGGTCAGTAGACTTTTACAGCTC-3′
1931–1954); and -actin, forward primer 5′-A AGAG AGG-
ATCCTCACCCT-3′, reverse primer 5′-TACATGGCTGGGG-
GTTGAA-3′. PCR products were analyzed by 1% agarose
el and visualized by ethidium bromide staining.
.5. Two-stage  skin  carcinogenesis  model
The inhibition of tumor promoting activity of GL was exam-
ned by a standard initiation promotion with DMBA and TPA,
s reported previously [19]. A group of 12 female ICR mice
ere given commercial rodent pellets and fresh tap water ad
ibitum, both of which were changed twice a week. The dor-
al region of each mouse was shaved with an electric clipper 2
ays before initiation. Mice at the age of 6 weeks were adminis-
rated with 200 nmol DMBA in 200 L of acetone, while control
ice received only 200 L of acetone. One week after initiation,
he mice were topically treated with 200 L of acetone or pro-
oted with TPA (5 nmol in 200 L acetone) twice a week for
0 weeks. For the other 2 groups, the mice were treated with GL
100 L) 30 min before each TPA treatment. Tumors of at least
 mm in diameter (measured using an electronic digital caliper)
ere counted and recorded twice weekly and the diameters of
kin tumors were measured at the same time. The results were
xpressed as the average number of tumors per mouse, percent-
ge of tumor-bearing mice and size distribution of tumors in
ach mouse.
.6. Molecular  mechanism  analysis  (inflammatory  and
ngiogenic events)
The skin/papilloma tissue was removed using a scalpel,
nd samples were placed on ice prior to removal of fat
y scraping. The samples were then homogenized in the
ysis buffer [50 mM Tris–HCl, pH 7.4, 1 mM NaF, 150 mM
aCl, 1 mM ethylene glycol-bis(aminoethylether)-tetraacetic
cid, 1 mM phenylmethanesulfonyl fluoride, 1% NP-40 and
0 g/mL leupeptin]. The homogenate was clarified by centrifu-
ation at 12,000 ×  g  for 20 min at 4 ◦C. COX-2, iNOS, VEGF
nd ODC were detected with western blot analysis using specific
ntibodies.
.7. HPLC  (high  performance  liquid  chromatography)
ystem  and  conditions.7.1.  Separation  and  quantification  of
olymethoxyflavones
The HPLC was equipped with a reversed phase amide C16
olumn (Ascentis RP-Amide, 3 m, 150 mm ×  4.6 mm ID),
m
s
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rom Supelco (Bellefonte, PA, USA). Gradient elution was used
ith a mobile phase composed of water (solvent A) and acetoni-
rile (ACN, solvent B). The optimized condition is as follows: a
0 min gradient was started with 40% of B, linearly increased to
5% of B in 10 min, then linearly increased to 70% in 15 min,
nd finally ramped to 80% in 20 min. Flow rate was 1.0 mL/min
nd the column temperature was maintained at 35 ◦C. Detec-
ion wavelength was 326 nm and the injection volume
as 10 L.
.7.2.  Measurement  of  other  flavonoids
The HPLC was equipped with a reversed phase C18 column
Luna C18(2), 3 m, 150 mm ×  4.6 mm ID), from Phenomenex,
nc. (Torrance, CA, USA). Gradient elution was used with a
obile phase composed of water containing 0.2% acetic acid
solvent A) and methanol containing 0.2% acetic acid (solvent
). The optimized conditions were as follows: a 100 min run
as started with 0% of B and kept as isocratic for 2 min, lin-
arly increased to 6% of B in 6 min and kept as isocratic for
 min, then to 20% in 5 min and kept as isocratic for 18 min,
hen to 40% of B in 50 min. The flow rate was 0.8 mL/min and
he column temperature was maintained at ambient temperature.
he detection wavelength was 283 nm and the injection volume
as 10 L.
. Results
.1.  Inhibitory  effects  of  GL  on  TPA-induced  iNOS  and
OX-2 expression  in  mouse  skin
Using TPA-induced acute inflammatory response model in
ouse skin, we investigated the anti-inflammatory effects of
L. Having induced both iNOS and COX-2 expression by TPA
reatment in mouse skin, we measured the protein expression of
NOS and COX-2 by western blot analysis. Female ICR mice
ere topically treated on their shaved backs with GL (100 and
00 L, respectively) 30 min prior to treatment with 10 nmol
PA. The mice were killed by cervical dislocation at 1 h, 2 h, and
 h. For protein and RNA isolation from mouse skin, the dorsal
kin of mice derived from different experiments was excised.
he epidermal protein and RNA were extracted and subjected
o western blot and RT-PCR analysis.
As shown in Fig. 1A, when TPA was applied topically on the
haved area (backs) of female ICR mice, the levels of iNOS and
OX-2 proteins were markedly increased compared to the neg-
tive control group. However, topical application of 100 L and
00 L GL 30 min prior to TPA treatment resulted in a dramatic
eduction in the level of iNOS protein. In the RT-PCR analy-
is (Fig. 1B), the topical application of GL also significantly
educed TPA-induced iNOS gene expression in mouse skin.
ence, we have found that GL inhibited both iNOS gene and
rotein expression in a dose-dependent manner in TPA-treated
ouse skin, but not COX-2 (Fig. 1A and B).
The ODC protein is a rate-limiting enzyme involved in the
ynthesis of polyamines that play a pivotal role in cell growth and
roliferation [20]. Induced ODC expression is also recognized as
68 M.-H. Pan et al. / Food Science and H
Fig. 1. Inhibitory effects of GL on the expression of TPA-induced iNOS and
COX-2 genes and proteins. (A) Mice were treated topically with 100 or 200 L
of GL 30 min prior to the treatment of 10 nmol TPA, and the mice were killed
at 2 and 4 h, respectively, after the TPA treatment. The epidermal proteins were
analyzed for iNOS, COX-2 and ODC by western blotting analysis. The western
blot is a representative of at least three independent experiments. (B) Mice were
treated as described in the text, and animals were killed at 1 and 2 h, respectively,
after TPA treatment. A total of 2 g of complementary DNA were subjected to
RT-PCR analysis for iNOS and COX-2 gene expression. (C) Quantification of
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When GL (100 L) was applied to the shaven backs of miceNOS and COX-2 gene expression was performed by densitometric analysis of
he agarose gel. *P < 0.01, **P  < 0.001 compared to the TPA group.
 biochemical hallmark of tumor promotion [21]. As illustrated
n Fig. 1A, topical application of 100 L and 200 L of GL
0 min prior to TPA treatment resulted in a dramatic reduction
n the levels of ODC proteins.
.2. Inhibitory  effect  of  GL  on  TPA-induced  epidermal
yperplasia in  mouse  skin
An inhibition study of GL against TPA-induced inflammation
as also performed. As shown in Fig. 2, TPA application at a
ose of 10 nmol led to marked edema, and an increase in epider-
al thickness of 13.2 ±  0.7 m was observed in the TPA treated
roup, versus  5.4 ±  1.9 m in the acetone group. Pre-treatment
3
w
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ith 100 L and 200 L of GL prior to TPA application dra-
atically suppressed epidermal thickness in a dose-dependent
anner (10.1 ±  1.3 m in 100 L GL group and 8.9 ±  1.4 m
n 200 L GL group; P  < 0.05, respectively). In addition, histo-
ogical examination analysis (Fig. 2A, arrow) revealed a higher
umber of leukocytes with infiltrated dermis due to the TPA
pplication as compared with the acetone group. Hence, pre-
reatment with 100 L and 200 L of GL reduced leukocyte
nfiltration.
.3. Inhibition  of  tumor  promotion  by  GL  (two-stage  skin
arcinogenesis model)
The mouse skin model of multi-stage carcinogenesis, which
s divided into 3 distinct stages, initiation, promotion, and pro-
ression [8], serves as a major in  vivo  model for studying
he sequential and stepwise evolution of the cancer process
y chemical and physical carcinogens. In this well-established
nd standardized model, a single sub-carcinogenic dose of skin
arcinogen such as DMBA, which causes irreversible DNA dam-
ge, is first applied topically. Then, the repeated application of
kin promoters, most commonly used phorbol esters such as
PA, to induce cell proliferation and inflammation was followed
22]. This process promotes the selective clonal expansion of
nitiated epidermal cells and leads to the formation of multiple
quamous papillomas. The mouse skin carcinogenesis model
ot only establishes a link between genetic pathways and histo-
ogical stages of tumor development but also serves as a model
or function evaluation of phytochemicals and natural products
23].
.4. Tumor  inhibitory  activity  of  GL  on  mouse  skin
Up regulation of iNOS, COX-2 and ODC occurs in many
athological conditions, such as in tumorigenesis. Because the
pplication of GL (100 and 200 L) to mouse skin significantly
nhibited various molecular targets that play significant roles in
he progression of skin tumors (Fig. 1), we employed the two-
tage skin carcinogenesis model to assess the inhibition of tumor
romoting potential of GL. As shown in Table 1, no differences
ere observed in the body weights of mice in each group. Simi-
arly, no any unhealthy symptoms were observed throughout the
tudy. Furthermore, no significant difference was observed in the
ean weights of liver, spleen and kidney, and no pathologic alter-
ations were found among the groups (Table 1). These results
uggested no noticeable side effects and no toxicity caused by
he administration of GL during a period of 20 weeks in the
wo-stage skin carcinogenesis model.
At the end of the study, the skin tumors of each group were
ollected. In the analysis of tumor incidence, the animals in
c/TPA group exhibited 16 ±  3 papillomas per mouse and
00% incidence of skin tumors at 20 weeks (Fig. 3A), whereas
ice treated with acetone exhibited no tumor development.0 min prior to each TPA application, the number of papillomas
as 12 ±  4 (reduced by 25% compared to the Ac/TPA group;
 < 0.05). In addition, we also found that the tumor incidence
M.-H. Pan et al. / Food Science and Human Wellness 1 (2012) 65–73 69
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pig. 2. Inhibitory effects of GL on TPA-induced skin thickness in mouse skin
reatment of 10 nmol TPA. After 24 h, all mice were killed for histological exam
as 100% in the Ac/TPA group, whereas the GL-treated group
howed significant reduction by 18% (Fig. 3B). Comparing the
eight of the tumors in all groups, tumor weight in the Ac/TPA
roup was 0.31 ±  0.12 g, whereas it was significantly decreased
o 0.11 ±  0.07 g in the GL-treated group (Fig. 3C).
.5. Inhibition  of  GL  on  tumor  size  and  the  expression  of
ngiogenic  molecules  in  mouse  skin  tumors
Tumor promotion data were analyzed in terms of size dis-
ribution of papillomas and compared with the Ac/TPA group.
w
C
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V
able 1
ffects of GL on body weight and organ weight in two-stage skin carcinogenesis mo
roup Treatment Number of mice Body wei
 Ac/Ac 11 30.8 ± 1
 Ac/TPA 11 30.5 ± 0
 100 L GL/TPA 11 30.0 ± 0
ote: Tumor promotion in all mice was initiated with DMBA (200 nmol) and promoted
pplied 30 min prior to each TPA treatment. Mice in each group were killed by deca
hotographed, weighted. (100 or 200 L) was topically applied to the dorsal skin 30 min prior to the
on and analysis of epidermal thickness (m) as described in Section 2.
he number of papillomas (≥5 mm in diameter) per mouse was
ignificantly reduced in the GL treated group (9 ±  2 in Ac/TPA
roup vs.  6 ±  1 in GL treated group, Fig. 4A). Additionally,
n mouse skin tumors initiated by DMBA and promoted by
PA for 20 weeks, the protein expression of ODC, COX-2
nd VEGF were markedly increased compared to skin tis-
ue from the Ac/Ac group (Fig. 4B). However, treatment
ith GL (100 L) resulted in the strong reduction of ODC,
OX-2 and VEGF protein levels in skin tumors. Because
DC is involved in cancer proliferation and both COX-2 and
EGF contribute to angiogenesis, these results suggested that
del.
ght (g) Liver (g) Spleen (g) Kidney (g)
.0 2.0 ± 0.2 0.14 ± 0.03 0.56 ± 0.08
.8 1.9 ± 0.2 0.20 ± 0.06 0.58 ± 0.05
.5 1.8 ± 0.2 0.24 ± 0.04 0.55 ± 0.14
 with TPA (5 nmol) twice weekly after 1 week initiation. GL (100 L) topically
pitation at the end of week 20, and the liver, spleen and kidney were removed,
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Fig. 3. Effect of GL on TPA-promoted skin carcinogenesis. Tumor formation in
all mice was initiated with DMBA (200 nmol) and promoted with TPA (5 nmol)
twice weekly after 1 week initiation. GL (100 L) topically applied 30 min prior
to each TPA treatment. Tumors with 1 mm or larger in diameter were counted
and recorded weekly, as described in Section 2. (A) Average number of papil-
lomas/mouse. (B) Percentage of mice with papillomas (P < 0.05). (C) Tumor
weight per mouse (g). *P < 0.05 indicates statistically significant differences
from the Ac/TPA treated group.
Fig. 4. Effect of GL on tumor diameter in DMBA/TPA-induced skin tumori-
genesis. During the period of tumor promotion, the diameters (in millimeter) of
skin tumors were measured by an electronic digital caliper twice a week. The
tumor dimension was recorded as the average of length × width (square millime-
ter) per mouse. Statistical analysis was completed by Student’s t-test. *P < 0.05
indicates statistically significant differences from the Ac/TPA treated group. (B)
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bffect of GL on angiogenesis in skin tumors. COX-2, ODC, and VEGF were
valuated with western blotting analysis using specific antibodies.
L reduced tumor size by inhibiting both tumor growth and
ngiogenesis.
. Discussion
In this study, we evaluated the in  vivo  anti-inflammatory,
nti-tumor efficacy of the citrus peel product GL, and a pos-
ible mechanism involved in using TPA-induced inflammation
n mouse skin model and DMBA/TPA two-stage skin car-
inogenesis model was proposed. Based on the results of
he TPA-induced skin inflammation model, pre-treatment with
00 L and 200 L GL prior to TPA application significantly
nhibited the inflammatory enzyme iNOS gene and protein
xpression, but not COX-2. These differential effects may
e due to the degree of dependency of iNOS and COX-2
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romoters on various transcription factors. It has been reported
hat the promoter regions of iNOS and COX-2 contain dif-
erent binding sites for transcription factors. Therefore, the
ranscriptional regulation of iNOS and COX-2 can be differen-
iated. The iNOS promoter contains several cis-acting elements
uch as nuclear factor-B (NF-B), activator protein-1 (AP-1),
CAAT/enhancer binding protein (C/EBP) , and signal trans-
ucers and activators of transcription protein (Stat), while the
OX-2 promoter has NF-B, C/EBP, and cAMP response ele-
ent (CRE) cis-acting elements [24,25]. Thus, the GL generated
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lavonoid contents in citrus peel extract (GL).
o. Flavonoids 
Nobiletin
 Sinesetin 
 Tangeretin 
 3,5,6,7,8,3′,4′-Hepta-methoxyflavone 
 3,5,6,7,3′,4′-Hexamethoxy-flavone 
 5,6,7,4′-Tetramethoxy-flavone 
otal PMFs in GL 
5pt] 7 Naringin 
 Hesperidin 
wo measured flavonoids in GL 
otal measured flavonoids in GLuman Wellness 1 (2012) 65–73 71
epression of TPA-induced iNOS expression but not COX-2 may
e completely through the regulation of different upstream tran-
cription. It is possible that GL may interfere with the enzyme
ctivity of COX-2, but not at the transcriptional level. Further
alidation for this proposed mechanism is warranted. In our
revious study, it is found similar results with dihydrolipoic
cid (DHLA): DHLA significantly suppressed iNOS expression,
hile only showed weak suppression toward the expression of
OX-2 protein induced by TPA. However, it has demonstrated
irect inhibition of COX-2 activity [26].
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[12] H. Ohshima, H. Tazawa, B.S. Sylla, T. Sawa, Prevention of human cancer2 M.-H. Pan et al. / Food Science 
Induction of ODC occurs in response to TPA treatment in
ouse skin, and ODC is constitutively elevated in the result-
ng skin tumors [27]. Applications of TPA to mouse skin led to
pidermal hyperplasia and excessive leukocyte recruitment and
nfiltration [28,29]. In this study, TPA-induced hyperplasia and
eukocyte infiltration were also reduced by pretreatment with
L. Moreover, a decreased protein level of ODC by GL pre-
reatment was observed as a result of GL pretreatment. These
esults suggest that GL inhibited TPA-induced skin inflam-
ation via  down regulation of inflammatory iNOS and ODC
xpression in mouse skin.
It is confirmed the inhibitory activity of GL on tumor using
wo-stage skin carcinogenesis model. At the end of the 20-
eek study, body weight and gross organ analyses revealed that
ong-term treatment with GL did not produce noticeable toxicity
ffects. Pre-treatment with GL suppressed DMBA/TPA-induced
kin tumor number and incidence as well as tumor weight.
esults of tumor size distribution demonstrated that GL signifi-
antly reduced the number of larger tumors (≥5 mm), suggesting
hat GL may hinder tumor growth, especially in larger tumors. To
nvestigate the anti-tumor promotion activity of GL, we collected
he skin tumors and performed western blot analysis. The results
howed that the protein levels of ODC were strongly decreased
n skin tumors in GL-treated mice. Angiogenesis is the process
f forming new blood vessels from pre-existing vessels and is
n essential process for solid tumor growth, invasion and metas-
asis. Up regulation of VEGF is a major angiogenic stimulus
n mouse epidermal carcinogenesis [30]. In addition to its role
f inflammation, COX-2 is also an important mediator of angio-
enesis and tumor growth [31]. In this study, it is found that both
OX-2 and VEGF protein levels were dramatically decreased in
he GL-treated group. Thus, these results demonstrated that GL
reatment effectively reduced tumorigenesis induced by topical
pplication of DMBA/TPA through inhibiting cell proliferation
nd tumor angiogenesis. Based on the afore mentioned results,
e suggest that GL possesses strong chemo-preventive effect
gainst DMBA/TPA-induced skin carcinogenesis via  the mech-
nisms of down-regulation of inflammation, proliferation and
ngiogenesis.
Our chemical analysis revealed that the formulated GL
roduct, composed of 6 citrus peels, was rich in flavonoids with
 total measured content of at least 450 ppm or 0.45 mg/mL, in
hich its polymethoxyfavone content was as high as 106 ppm
r 0.1 mg/mL (Table 2). The net amount of flavonoids present,
.e. dosage level, does not adequately explain the efficacy
r effectiveness of anti-inflammatory and anti-carcinogenic
roperties of GL in the prevention and treatment of human
iseases such as melanoma or prostate cancer. Nonetheless,
he overall content and formulation of this specific citrus peel
roduct presents a unique chemical profile leading to strong
nti-inflammation and anti-cancer activity in our tested mouse
kin model. Therefore, based on the results of this study, we
xpect that the potential synergistic effects among the rich
avonoids in this formulated citrus extract, particularly poly-
ethoxyflavones and traditionally recognized flavonoids, mayccount for its efficacy and effectiveness against inflammation
nd cancer expressed in the well-established mouse skin model.uman Wellness 1 (2012) 65–73
. Conclusion
The growing demand and the vast potential for natural prod-
cts to serve as safe and efficacious therapeutic agents continues
o garner increasing attention. However, plant extracts with
omplex chemical profiles must be rigorously evaluated and
hemically characterized to insure adequate performance con-
istency with respect to biological activity. The objectives in this
tudy are to disentangle the complexity of the natural products
erived from citrus peels; to comprehend the chemical profile
nd efficacy of GL; to establish a potential SAR (structure activ-
ty relationship); to explore purported synergistic effects; and
ore importantly, to gain maximum benefits from this safe and
fficacious citrus peel products. Based on our findings, it is
uggested that GL promotes a strong protective effect against
PA-mediated epithelial carcinogenesis via  inhibition of COX-
, ODC, and VEGF expression. This is the first investigation with
olid evidence indicating the potential of GL as a novel chemo-
reventive agent in the treatment of inflammation-associated
umorigenesis.
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